Bio-Rad Labs Inc. A buy UBS Group AG
Start price
03.05.25
/
50%
€205.90
Target price
03.05.26
€274.38
Performance (%)
3.59%
Price
16.07.25
€212.40
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 3.59%. This prediction currently runs until 03.05.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Rad Labs Inc. A | 0.664% | 0.664% |
| iShares Core DAX® | -1.691% | 2.604% |
| iShares Nasdaq 100 | 0.913% | 3.716% |
| iShares Nikkei 225® | -2.346% | -1.208% |
| iShares S&P 500 | 0.732% | 3.130% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $355.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
-12.97%
09.05.25
09.05.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
8.65%
08.12.24
08.12.24